Genetic variation near the interferon lambda 3 (IFNL3) is known to be associated with response to pegylated interferon (pegIFN) and ribavirin combination therapy in patients with chronic hepatitis C virus (HCV) infection which is often accompanied by hepatic steatosis. | Association of IFNL3 genotype with hepatic steatosis in chronic hepatitis C patients treated with peginterferon and ribavirin combination therapy